Podcast Episodes
Back to Search
Breast Cancer: Additional Perspectives — Year in Review Series on Relevant New Datasets and Advances
Season 25 Episode 21
Dr Ian Krop from Yale Cancer Center in New Haven, Connecticut, and Dr Sara Tolaney from Dana-Farber Cancer Institute in Boston, Massachusetts, summar…
1 year ago
5-Minute Journal Club Issue 8 with Dr Rinath M Jesselsohn: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
Season 25 Episode 20
Dr Rinath Jeselsohn from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with oral SERDs in the management o…
1 year ago
5-Minute Journal Club Issue 7 with Dr Rinath M Jesselsohn: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer
Season 25 Episode 19
Dr Rinath M Jeselsohn from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with oral SERDs in the management…
1 year ago
Breast Cancer — Year in Review Series on Relevant New Datasets and Advances
Season 25 Episode 18
Dr Rebecca Dent from National Cancer Centre Singapore and Dr Nancy Lin from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss important …
1 year, 1 month ago
For Oncology Nurses: Antibody-Drug Conjugates for Breast Cancer and Lung Cancer — Proceedings from the 2025 Annual ONS Congress
Season 25 Episode 17
Dr Edward B Garon, Dr Tiffany A Traina, and nurse practitioners Ms Marianne J Davies and Ms Marissa Marti-Smith discuss the role of antibody-drug con…
1 year, 1 month ago
Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy
Season 25 Episode 16
Dr Adam M Brufsky from the University of Pittsburgh discusses first-line treatment selection for patients with HR-positive metastatic breast cancer a…
1 year, 1 month ago
HER2-Positive and Triple-Negative Breast Cancer — Fourth Annual National General Medical Oncology Summit
Season 25 Episode 15
Clinical investigators discuss available data guiding the management of HER2-positive, triple-negative and localized breast cancer.
CME information …
1 year, 1 month ago
HR-Positive Breast Cancer — Fourth Annual National General Medical Oncology Summit
Season 25 Episode 14
Clinical investigators discuss available data guiding the management of hormone receptor-positive metastatic breast cancer.
CME information and selec…
1 year, 1 month ago
Breast Cancer — An Interview with Dr Adrienne G Waks on Recent Trial Updates
Season 25 Episode 13
Dr Adrienne G Waks from Dana-Farber Cancer Institute in Boston, Massachusetts, reviews recent trial updates and their significance for the management…
1 year, 2 months ago
Neurofibromatosis Type 1 Plexiform Neurofibromas — An interview with Dr Christopher L Moertel
Season 25 Episode 12
Dr Christopher L Moertel from the University of Minnesota in Minneapolis discusses the clinical presentation of and optimal management strategies for…
1 year, 2 months ago